EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Is There A Role for Limited Parotid Resections for Primary Malignant Parotid Tumors?

Miquel Quer, Kerry D. Olsen, Carl E. Silver, Marc Hamoir, Antti A. Mäkitie, Juan P. Rodrigo, Vincent Vander Poorten, Robert P. Takes, Henrik Hellquist, Jacinto García Lorenzo, Orlando Guntinas-Lichius, Remco de Bree, Carlos Suárez, Luiz P. Kowalski, José G. Vartanian, Alvaro Sanabria, Ashok R. Shaha, Peter Zbären, Alessandra Rinaldo, Alfio Ferlito

Surgeries · 2020

DOI: 10.3390/surgeries1010002 ↗
AbstractBibliografische Angaben

Abstract

(1) Background: Lateral or total parotidectomy are the standard surgical treatments for malignant parotid tumors. However, some authors have proposed a more limited procedure. (2) Methods: We performed a review of the literature on this topic. Studies were included that met the following criteria: malignant parotid tumors, information about the extent of surgical resection, treated with less than a complete lateral lobectomy, and information on local control and/or survival. Nine articles fulfilled the inclusion criteria. (3) Results: Eight of the nine series reported favorable results for the more limited approaches. Most used them for small, mobile, low-grade cancers in the lateral parotid lobe. Most authors have used a limited partial lateral lobectomy for a presumed benign lesion. The remaining study analyzed pediatric patients treated with enucleation with poor local control. (4) Conclusions: There is weak evidence for recommending less extensive procedures than a lateral parotid lobectomy. In the unique case of a partial lateral parotidectomy performed for a tumor initially thought to be benign but pathologically proved to be malignant, close follow-up can be recommended for low grade T1 that has been excised with free margins and does not have adverse prognostic factors.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →